Literature DB >> 19036592

Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid benzylidene-carbohydrazide series.

Maria A F Vera-Divaio1, Antônio C C Freitas, Helena C Castro, Sérgio de Albuquerque, Lucio M Cabral, Carlos R Rodrigues, Magaly G Albuquerque, Rita C A Martins, Maria G M O Henriques, Luiza R S Dias.   

Abstract

Chagas disease (American trypanosomiasis) is one of the most important parasitic diseases with serious social and economic impacts mainly on Latin America. This work reports the synthesis, in vitro trypanocidal evaluation, cytotoxicity assays, and molecular modeling and SAR/QSAR studies of a new series of N-phenylpyrazole benzylidene-carbohydrazides. The results pointed 6k (X=H, Y=p-NO2, pIC(50)=4.55 M) and 6l (X=F, Y=p-CN, pIC(50)=4.27 M) as the most potent derivatives compared to crystal violet (pIC(50)=3.77 M). The halogen-benzylidene-carbohydrazide presented the lowest potency whereas 6l showed the most promising profile with low toxicity (0% of cell death). The best equation from the 4D-QSAR analysis (Model 1) was able to explain 85% of the activity variability. The QSAR graphical representation revealed that bulky X-substituents decreased the potency whereas hydrophobic and hydrogen bond acceptor Y-substituents increased it.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036592     DOI: 10.1016/j.bmc.2008.10.085

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Magnetically recoverable Fe3O4 nanocatalyst for the synthesis of biodynamically significant 1H-pyrazolo[1,2-b]phthalazine-5,10-diones derivatives and its DFT study.

Authors:  Mohd Danish Ansari; Hozeyfa Sagir; Vijay B Yadav; Neetu Yadav; Ankit Verma; Sonam Shakya; Manjit Singh; I R Siddiqui
Journal:  Mol Divers       Date:  2022-10-07       Impact factor: 3.364

2.  (2E)-2-(4-Bromo-benzyl-idene)-2,3-di-hydro-1H-inden-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Khulud F Al-Nemari; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-17

3.  (2E)-2-[(2E)-3-Phenyl-prop-2-en-1-yl-idene]-2,3-dihydro-1H-inden-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Khulud F Al-Nemari; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-24

4.  2-[(E)-4-Meth-oxy-benzyl-idene]-1,2,3,4-tetra-hydro-naphthalen-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Mohie E M Zayed; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-23

5.  (2E)-2-(Thio-phen-2-yl-methyl-idene)-1,2,3,4-tetra-hydro-naphthalen-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Khalid A Alamry; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-30

6.  1-Phenyl-1H-pyrazole-4-carbaldehyde.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Tariq R Sobahi; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-17

7.  2-[1-(1-Oxoindan-2-yl)eth-yl]indan-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Khalid A Alamry; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-04

8.  (2E)-2-(Furan-2-yl-methyl-idene)-2,3-dihydro-1H-inden-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Khulud F Al-Nemari; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-14

9.  (2E)-2-[(2H-1,3-Benzodioxol-5-yl)methyl-idene]-2,3-dihydro-1H-inden-1-one.

Authors:  Abdullah M Asiri; Hassan M Faidallah; Khulud F Al-Nemari; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-10

10.  Pyrazole carbohydrazide derivatives of pharmaceutical interest.

Authors:  Luiza Rosaria Sousa Dias; Raquel Rocha Silva Salvador
Journal:  Pharmaceuticals (Basel)       Date:  2012-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.